<--- Back to Details
First PageDocument Content
Medicine / Eli Lilly and Company / Gastroenterology / Anti-diabetic drugs / Recombinant proteins / Exenatide / Anti-diabetic medication / Insulin analog / Insulin glargine / Endocrine system / Diabetes / Peptide hormones
Date: 2014-10-29 12:18:25
Medicine
Eli Lilly and Company
Gastroenterology
Anti-diabetic drugs
Recombinant proteins
Exenatide
Anti-diabetic medication
Insulin analog
Insulin glargine
Endocrine system
Diabetes
Peptide hormones

OctoberINSULIN USE FOR TYPE 2 DIABETES MANAGEMENT WHAT INSULIN REGIMEN SHOULD

Add to Reading List

Source URL: www.medicalpharmacies.com

Download Document from Source Website

File Size: 380,88 KB

Share Document on Facebook

Similar Documents

Texas Business Group on HealthTEXAS TYPE

Texas Business Group on HealthTEXAS TYPE

DocID: 1qBzC - View Document

Asian Pacific Journal of Tropical DiseaseContents lists available at ScienceDirect Asian Pacific Journal of Tropical Disease journal homepage:www.elsevier.com/locate/apjtd

Asian Pacific Journal of Tropical DiseaseContents lists available at ScienceDirect Asian Pacific Journal of Tropical Disease journal homepage:www.elsevier.com/locate/apjtd

DocID: 1qBbb - View Document

actos vs januvia. actos 1.2 mg. actos 30 mg side effects glimeperide with actos and januvia. what is ursus actos, actos goes generic. actos corporation januvia vs actos lawyer for actos lawsuitque son los actos pr

actos vs januvia. actos 1.2 mg. actos 30 mg side effects glimeperide with actos and januvia. what is ursus actos, actos goes generic. actos corporation januvia vs actos lawyer for actos lawsuitque son los actos pr

DocID: 1qAuT - View Document

Zuercher_HealthLiteracy_2014_VFinal

Zuercher_HealthLiteracy_2014_VFinal

DocID: 1qrty - View Document

Peytremann-Bridevaux et al. BMC Health Services Research 2013, 13:232 http://www.biomedcentral.com RESEARCH ARTICLE  Open Access

Peytremann-Bridevaux et al. BMC Health Services Research 2013, 13:232 http://www.biomedcentral.com RESEARCH ARTICLE Open Access

DocID: 1qj8G - View Document